Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

52
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
52
MicroRNAs01:22

MicroRNAs

21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
MicroRNAs01:22

MicroRNAs

9.8K
9.8K
MicroRNAs01:22

MicroRNAs

3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

1.2K
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.2K
Nephrons01:10

Nephrons

8.5K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
8.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cough burden in progressive pulmonary fibrosis: a systematic review with narrative synthesis.

Health and quality of life outcomes·2026
Same author

Safety, Pharmacokinetics, and Pharmacodynamics of SHR6508, a Calcium-Sensing Receptor Agonist, in Maintenance Hemodialysis Patients With Secondary Hyperparathyroidism: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.

Kidney medicine·2026
Same author

Bone morphology as a significant risk factor for anterior cruciate ligament injury.

NPJ digital medicine·2026
Same author

Prevalence of anxiety and depression in idiopathic pulmonary fibrosis: a systematic review and meta-analysis.

BMC pulmonary medicine·2026
Same author

Identification of end-stage renal disease-associated loci in X chromosome: an X chromosome-wide association study.

MedScience·2026
Same author

Bone Marrow-Derived Macrophage NLRP3 Mediates Renal Fibrosis by triggering TGF-β/Smad3-mediated Macrophage-Myofibroblast Transition.

International journal of biological sciences·2026

Related Experiment Video

Updated: May 7, 2026

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
12:21

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues

Published on: November 30, 2013

14.2K

MicroRNA and nephropathy: emerging concepts.

Arthur Ck Chung1, Xueqing Yu, Hui Y Lan

  • 1Li Ka Shing Institute of Health Sciences and Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, People's Republic of China ; CUHK Shenzhen Research Institute, Shenzhen, People's Republic of China.

International Journal of Nephrology and Renovascular Disease
|October 11, 2013
PubMed
Summary

Micro ribonucleic acids (miRNAs) play key roles in kidney diseases. Understanding their function offers new diagnostic and therapeutic strategies for renal fibrosis.

Keywords:
TGF-β signalingkidney diseasesmicroRNAsrenal fibrosis

More Related Videos

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
07:01

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model

Published on: September 11, 2020

1.4K
Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
07:01

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Published on: May 10, 2022

1.6K

Related Experiment Videos

Last Updated: May 7, 2026

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
12:21

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues

Published on: November 30, 2013

14.2K
A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
07:01

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model

Published on: September 11, 2020

1.4K
Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
07:01

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Published on: May 10, 2022

1.6K

Area of Science:

  • Molecular Biology
  • Genetics
  • Nephrology

Background:

  • Micro ribonucleic acids (miRNAs) are short noncoding RNAs regulating gene expression.
  • Aberrant miRNA expression is linked to human diseases, particularly kidney diseases.
  • Renal fibrosis, a hallmark of chronic kidney diseases, involves extracellular matrix deposition mediated by transforming growth factor beta (TGF-β).

Purpose of the Study:

  • To explore the role of miRNAs in renal pathophysiology.
  • To investigate the relationship between TGF-β signaling and miRNA expression in kidney diseases.
  • To highlight the potential of miRNAs as biomarkers and therapeutic targets for renal diseases.

Main Methods:

  • Review of clinical and experimental animal studies on miRNA involvement in renal fibrosis.
  • Analysis of TGF-β signaling pathways and their regulation of specific miRNAs (e.g., miR-21, miR-192, miR-200, miR-29).
  • Evaluation of circulating and urinary miRNA levels as potential diagnostic markers.

Main Results:

  • TGF-β signaling differentially regulates miRNAs: miR-192 and miR-21 are upregulated and play pathological roles.
  • miR-29 and miR-200 families are downregulated by TGF-β, exhibiting protective effects against fibrosis and epithelial-to-mesenchymal transition.
  • Circulating and urinary miRNAs show potential as early diagnostic biomarkers for renal diseases.

Conclusions:

  • miRNAs are critical regulators in kidney disease pathogenesis, particularly renal fibrosis.
  • Targeting specific miRNAs presents a promising therapeutic avenue for chronic kidney diseases.
  • Further research into miRNA mechanisms is essential for advancing early diagnosis and treatment strategies.